These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7056975)

  • 1. Combination therapy for osteoporosis with estrogen, fluoride, and calcium.
    Aloia JF; Zanzi I; Vaswani A; Ellis K; Cohn SH
    J Am Geriatr Soc; 1982 Jan; 30(1):13-7. PubMed ID: 7056975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.
    Riggs BL; Seeman E; Hodgson SF; Taves DR; O'Fallon WM
    N Engl J Med; 1982 Feb; 306(8):446-50. PubMed ID: 6276746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal osteoporosis: treatment with low-dose sodium fluoride and estrogen.
    Lueg MC
    South Med J; 1988 May; 81(5):597-600. PubMed ID: 2835819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutron activation studies and the effect of exercise on osteoporosis.
    Harrison JE
    J Med; 1984; 15(4):285-94. PubMed ID: 6597259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium.
    Ettinger B; Genant HK; Cann CE
    Ann Intern Med; 1987 Jan; 106(1):40-5. PubMed ID: 3789576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study.
    Pacifici R; McMurtry C; Vered I; Rupich R; Avioli LV
    J Clin Endocrinol Metab; 1988 Apr; 66(4):747-53. PubMed ID: 3126214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin.
    Aloia JF; Vaswani A; Meunier PJ; Edouard CM; Arlot ME; Yeh JK; Cohn SH
    Calcif Tissue Int; 1987 May; 40(5):253-9. PubMed ID: 2981045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of involutional bone loss by exercise.
    Aloia JF; Cohn SH; Ostuni JA; Cane R; Ellis K
    Ann Intern Med; 1978 Sep; 89(3):356-8. PubMed ID: 686549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-year changes in bone mineral mass of postmenopausal osteoporotic patients based on neutron activation analysis of the central third of the skeleton.
    Harrison JE; McNeill KG; Sturtridge WC; Bayley TA; Murray TM; Williams C; Tam C; Fornasier V
    J Clin Endocrinol Metab; 1981 Apr; 52(4):751-8. PubMed ID: 6970749
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen: prevention and treatment of osteoporosis.
    Lindsay R
    Postgrad Med; 1989 Apr; Spec No():7-9; discussion 33-43. PubMed ID: 2726631
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone mineral content in postmenopausal women: comparison of omnivores and vegetarians.
    Hunt IF; Murphy NJ; Henderson C; Clark VA; Jacobs RM; Johnston PK; Coulson AH
    Am J Clin Nutr; 1989 Sep; 50(3):517-23. PubMed ID: 2773831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring fluoride therapy in osteoporosis by dual photon absorptiometry.
    Raymakers JA; van Dijke CF; Hoekstra A; Duursma SA
    Bone; 1987; 8(3):143-8. PubMed ID: 3606905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral, serum calcium, and dietary intakes of mother/daughter pairs.
    Lutz J
    Am J Clin Nutr; 1986 Jul; 44(1):99-106. PubMed ID: 3728353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trial.
    Reid IR; Cundy T; Grey AB; Horne A; Clearwater J; Ames R; Orr-Walker BJ; Wu F; Evans MC; Gamble GD; King A
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2446-52. PubMed ID: 17440020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current problems in osteoporosis from the clinical and radiologic viewpoints].
    Hesch RD; Galanski M; Prokop M; Rittinghaus EF
    Radiologe; 1988 Apr; 28(4):143-8. PubMed ID: 3289079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and management of primary osteoporosis.
    Bauwens SF; Drinka PJ; Boh LE
    Clin Pharm; 1986 Aug; 5(8):639-59. PubMed ID: 3527528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study.
    Riis B; Thomsen K; Christiansen C
    N Engl J Med; 1987 Jan; 316(4):173-7. PubMed ID: 3540668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phonton absorptiometry and skeletal mass in the treatment of osteoporosis.
    Aloia JF; Ellis K; Zanzi I; Cohn SH
    J Nucl Med; 1975 Mar; 16(3):196-9. PubMed ID: 1113168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy.
    Christiansen C; Christensen MS; Transbøl I
    Lancet; 1981 Feb; 1(8218):459-61. PubMed ID: 6110089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis.
    Jowsey J; Riggs BL; Kelly PJ; Hoffmann DL
    Am J Med; 1972 Jul; 53(1):43-9. PubMed ID: 5037288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.